Observational studyInternational journal of cancer2021
Low-dose pembrolizumab in the treatment of advanced non-small cell lung cancer.
Jia Li Low et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this paperpooled ittrialcites it